Also found in: Dictionary.
Related to Aggrenox: dipyridamole


A proprietary combination drug (dipyridamole and aspirin) for preventing new stroke in patients who have suffered a TIA or completed ischaemic stroke.
Indications Pulmonary hypertension, reduces shunt failure in dialysis, increases tPA release from cerebrovascular endothelium, increases perfusion in patients with ischaemic cardiomyopathy.
Adverse effects Dyspepsia, abdominal pain, nausea, diarrhoea, vomiting, headache, haemorrhage, epistaxis, purpura, anaemia.
References in periodicals archive ?
BIPI claimed that Aggrenox was helpful for heart attacks and congestive heart failure and that it was superior to Plavix though they had no evidence to substantiate that claim.
Many doctors also preferred the dual action of Aggrenox and aspirin to Plavix from Bristol-Myers Squibb Co.
Specifically, the States allege BIPI: (1) misrepresented that its antiplatelet drug, Aggrenox, was effective for many conditions below the neck, such as heart attacks and congestive heart failure, and that it was superior to Plavix without evidence to substantiate that claim; (2) misrepresented that Micardis protected patients from early morning strokes and heart attacks and treated metabolic syndrome; (3) misrepresented that Combivent could be used as a first-line treatment for bronchospasms associated with chronic obstructive pulmonary disease (COPD); and (4) falsely stated that Atrovent and Combivent could be used at doses that exceeded the maximum dosage recommendation in the product labeling and that they were essential for treatment of COPD.
Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, has introduced generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States, it was reported on Friday.
M2 PHARMA-July 6, 2015-Teva launches Aggrenox capsules in US
Among patients who had experienced TIA but were not candidates for carotid surgery, Aggrenox was the most cost effective.
With the exception of Aggrenox, which is a combination of aspirin and sustained-release dipyridamole, none of the drug options have been studied in combination in patients with cerebrovascular disease.
Aggrenox, a mixture of low-dose aspirin and dipyridamole (both known to reduce blood's ability to clot), was recently approved by the U.
European physicians have found that stopping treatment with Aggrenox for a few days, restarting treatment at one capsule a day and increasing to two a day after a few days has helped people who develop headaches with initial treatment, said Dr.
BIPI) for alleged off-label marketing and deceptive practices used to promote four prescription drugs: Micardis, Aggrenox, Atrovent, and Combivent.
M2 EQUITYBITES-July 2, 2015-Teva unveils generic Aggrenox Capsules in the US